These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5473666)

  • 1. [Spirazidin in the complex treatment of lung cancer].
    Shkrob OS; Zharikov AA
    Khirurgiia (Mosk); 1970 Aug; 46(8):17-22. PubMed ID: 5473666
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of spirazidin in the treatment of inoperable patients with cancer of the lung].
    Shkrob OS; Zharikov AA
    Sov Med; 1966 Jun; 29(6):137-40. PubMed ID: 4168474
    [No Abstract]   [Full Text] [Related]  

  • 3. Radicality of surgery after inductive chemotherapy of bronchogenic cancer.
    Novák K; Pesek M; Tauchman A; Bürger J; Chudácek Z
    Acta Univ Palacki Olomuc Fac Med; 2000; 143():98-9. PubMed ID: 11144147
    [No Abstract]   [Full Text] [Related]  

  • 4. [After care of operated bronchogenic carcinoma with an atoxic antineoplastic agent].
    Hansen JL
    Ugeskr Laeger; 1975 Jun; 137(26):1466-9. PubMed ID: 1096394
    [No Abstract]   [Full Text] [Related]  

  • 5. Bronchogenic carcinoma: results of surgery plus RSV or without RSV.
    Hansen JL
    Bronches; 1974; 24(4):206-8. PubMed ID: 4429828
    [No Abstract]   [Full Text] [Related]  

  • 6. Small-cell bronchogenic carcinoma; advances in treatment.
    Bergevin PR
    N Y State J Med; 1980 Nov; 80(12):1847-50. PubMed ID: 6262689
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent therapeutic developments in lung cancer.
    Hansen HH; Selawry OS
    Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
    [No Abstract]   [Full Text] [Related]  

  • 8. Some thoughts on surgical adjuvant studies in lung cancer.
    Carter SK
    Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314
    [No Abstract]   [Full Text] [Related]  

  • 9. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
    González Aragoneses F
    Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiotherapy of bronchogenic carcinoma.
    Lee RE
    Semin Oncol; 1974 Sep; 1(3):245-52. PubMed ID: 4143487
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of an innoxious antineoplastic agent: preliminary study of 106 patients treated with or without RSV after pulmonary resection for bronchogenic carcinoma.
    Hansen JL
    Cancer Chemother Rep 3; 1973 Mar; 4(2):261-4. PubMed ID: 4729327
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
    Karrer K; Pridun N; Zwintz E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
    [No Abstract]   [Full Text] [Related]  

  • 13. Selecting appropriate therapy for bronchial carcinoma.
    Shields TW
    Geriatrics; 1974 Jul; 29(7):54-60. PubMed ID: 4835739
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
    Mountain CF
    Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor drugs in inoperable lung cancer.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1984; 26(1):60-1. PubMed ID: 6510992
    [No Abstract]   [Full Text] [Related]  

  • 16. [The present status of the prevention of malignant tumor recurrence].
    Karrer K
    Wien Klin Wochenschr; 1968 Feb; 80(7):116-23. PubMed ID: 5661515
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 18. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of a combination of cytostatics with substances influencing neuro-humoral regulation (K6) in the treatment of lung cancer.
    Jelínek V; Petríková J; Zlatkovská E; Rezábek K
    Neoplasma; 1971; 18(5):481-4. PubMed ID: 4399163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Does chemotherapy bring real benefit to patients with inoperable bronchial epidermoid cancer?].
    Depierre A
    Rev Mal Respir; 1986; 3(4):169-71. PubMed ID: 3786923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.